Glycaemic instability is an underestimated problem in Type II diabetes

Clinical Science

Volumn 111, Issue 2, 2006, Pages 119-126

  Praet, Stephan F E ^a   Manders, Ralph J F ^b   Meex, Ruth C R ^b   Lieverse, A G ^c   Stehouwer, Coen D A ^d   Kuipers, Harm ^a   Keizer, Hans A ^a   Van Loon, Luc J C ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MÁXIMA MEDICAL CENTER   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Continuous overall net glycaemic action (CONGA); Continuous subcutaneous glucose monitoring system (CGMS); Glycated haemoglobin (HbA1c); Hyperglycaemia; Type II diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; POSTPRANDIAL STATE; PRIORITY JOURNAL;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; DIET; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; MOTOR ACTIVITY; POSTPRANDIAL PERIOD;

EID: 33747128620     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20060041     Document Type: Article

References (36)

1. Maran, A., Crepaldi, C., Tiengo, A. et al. (2002) Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care 25, 347-352
2. Jungheim, K., Wientjes, K. J., Heinemann, L., Lodwig, V., Koschinsky, T. and Schoonen, A. J. (2001) Subcutaneous continuous glucose monitoring: feasibility of a new microdialysis-based glucose sensor system. Diabetes Care 24, 1696-1697
3. Schaepelynck-Belicar, P., Vague, P., Simonin, G. and Lassmann-Vague, V. (2003) Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (cgms). Diabetes Metab. 29, 608-612
4. Hay, L. C., Wilmshurst, E. G. and Fulcher, G. (2003) Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring. Diabetes Technol. Ther. 5, 19-26
5. Bounder, J., Hagstrom-Toft, E., Ungerstedt, U. and Arner, P. (1997) Self-monitoring of blood glucose in type I diabetic patients: comparison with continuous microdialysis measurements of glucose in subcutaneous adipose tissue during ordinary life conditions. Diabetes Care 20, 64-70
6. 1c in pediatric type 1 diabetic patients. Diabetes Care 25, 1840-1844
7. 1c. Ann. Clin. Biochem. 39, 516-517
8. Wolever, T. M. (1990) The glycemic index. World Rev. Nutr. Diet 62, 120-185
9. Burstein, R., Epstein, Y., Shapiro, Y., Charuzi, I. and Karnieli, E. (1990) Effect of an acute bout of exercise on glucose disposal in human obesity. J. Appl. Physiol. 69, 299-304
10. Bantle, J. P. and Laine, D. C. (1988) Day-to-day variation in glycemic control in type i and type ii diabetes mellitus. Diabetes Res. 8, 147-149
11. Kerssen, A., De Valk, H. W. and Visser, G. H. (2004) Day-to-day glucose variability during pregnancy in women with type 1 diabetes mellitus: glucose profiles measured with the continuous glucose monitoring system. Br. J. Obstet. Gynaecol. 111, 919-924
12. Wautier, M. P., Massin, P., Guillausseau, P. J. et al. (2003) N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients. Diabetes Metab. 29, 44-52
13. Ceriello, A. (2005) Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 54, 1-7
14. De Backer, G., Ambrosioni, E., Borch-Johnsen, K. et al. (2003) European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur. Heart J. 24, 1601-1610
15. Amerian Diabetes Association (2006) Standards of medical care in diabetes (2006). Diabetes Care 29, S4-S34
16. World Health Organisation (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus, World Health Organisation, Geneva
17. Mari, A., Pacini, G., Murphy, E., Ludvik, B. and Nolan, J. J. (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24, 539-548
18. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F. and Turner, R. C. (1985) Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419
19. Meyerhoff, C., Bischof, F., Sternberg, F., Zier, H. and Pfeiffer, E. F. (1992) On line continuous monitoring of subcutaneous tissue glucose in men by combining portable glucosensor with microdialysis. Diabetologia 35, 1087-1092
20. Ainsworth, B. E., Haskell, W. L., Whin, M. C. et al. (2000) Compendium of physical activities: An update of activity codes and met intensities. Med. Sci. Sports Exercise 32, S498-S504
21. McDonnell, C. M., Donath, S. M., Vidmar, S. I., Werther, G. A. and Cameron, F. J. (2005) A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol. Then 7, 253-263
22. Roy, R., Navar, M., Palomeno, G. and Davidson, M. B. (2004) Real world effectiveness of rosiglitazone added to maximal (tolerated) doses of metformin and a sulfonylurea agent: A systematic evaluation of triple oral therapy in a minority population. Diabetes Care 27, 1741-1742
23. Davies, M. (2004) The reality of glycaemic control in insulin treated diabetes: defining the clinical challenges. Int. J. Obes. Relat. Metab. Disord. 28 (Suppl. 2), S14-S22
24. Del Prato, S. (2002) In search of normoglycaemia in diabetes: Controlling postprandial glucose. Int. J. Obes. Relat. Metab. Disord. 26 (Suppl. 3), S9-17
25. Wiersma, T. J., Heine, R. J. and Rutten, G. E. (1999) Summary of the practice guideline 'diabetes mellitus type 2' (first revision) of the Dutch College of General Practitioners. Ned. Tijdschr. Geneeskd. 143, 1688-1691
26. Monnier, L., Colette, C., Rabasa-Lhoret, R. et al. (2002) Morning hyperglycemic excursions: a constant failure in the metabolic control of non-insulin-using patients with type 2 diabetes. Diabetes Care 25, 737-741
27. Aronson, D. and Rayfield, E. J. (2002) How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc. Diabetol. 1, 1
28. Spijkerman, A. M., Henry, R. M., Dekker, J. M. et al. (2004) Prevalence of macrovascular disease amongst type 2 diabetic patients detected by targeted screening and patients newly diagnosed in general practice: The Hoorn screening study. J. Intern. Med. 256, 429-436
29. Shorr, R. I., Franse, L. V., Resnick, H. E., Di Bari, M., Johnson, K. C. and Pahor, M. (2000) Glycemic control of older adults with type 2 diabetes: findings from the Third National Health and Nutrition Examination survey, 1988-1994. J. Am. Geriatr. Soc. 48, 264-267
30. UK prospective diabetes study (UKPDS) group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352, 837-853
31. Shichiri, M., Kishikawa, H., Ohkubo, Y. and Wake, N. (2000) Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 23 (Suppl. 2), B21-B29
32. Lerman-Garber, I., Lopez-Ponce, A., Murcio Flores, R. A. et al. (2001) Comparing easy and accessible parameters of glycemic control in type 2 diabetes. Rev. Invest. Clin. 53, 518-525
33. Murata, G. H., Hoffman, R. M., Duckworth, W. C., Wendel, C. S. and Shah, J. H. (2004) Contributions of weekly mean blood glucose values to hemoglobin ale in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Am. J. Med. Sci. 327, 319-323
34. Jeffcoate, S. L. (2004) Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabetic Med. 21, 657-665
35. 1c interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control. Diabetes Care 24, 2023-2029
36. Miyazaki, Y., Mahankali, A., Matsuda, M. et al. (2001) Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone. Diabetes Care 24, 710-719